Crinecerfont 11014-0665
Product NDC
11014-0665- Manufacturer
- Catalent Pharma Solutions, Llc
- Dosage Form
- Capsule
- Product Type
- Drug For Further Processing
- Marketing Start
- September 23, 2024
- Listing Expires
- December 31, 2027
Active Ingredients
| Ingredient | Strength |
|---|---|
| Crinecerfont | 50 mg/1 |
Packaging Options(1)
1 BAG in 1 CARTON (11014-0665-1) / 6000 CAPSULE in 1 BAG